Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APRI

Apricus Biosciences (APRI) Stock Price, News & Analysis

Apricus Biosciences logo

About Apricus Biosciences Stock (NASDAQ:APRI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2 shs
Average Volume
558,386 shs
Market Capitalization
$14 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive APRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apricus Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APRI Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
See More Headlines

APRI Stock Analysis - Frequently Asked Questions

Apricus Biosciences, Inc. (NASDAQ:APRI) posted its earnings results on Wednesday, October, 31st. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apricus Biosciences investors own include Scotts Miracle-Gro (SMG), Pfizer (PFE), Just Eat Takeaway.com (GRUB), Boston Beer (SAM), Amicus Therapeutics (FOLD), Synergy Pharmaceuticals (SGYP).

Company Calendar

Last Earnings
10/31/2018
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APRI
CIK
1017491
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$320 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-216.45%
Return on Assets
-153.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.86
Quick Ratio
3.86

Sales & Book Value

Annual Sales
$5.76 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,170,000
Free Float
N/A
Market Cap
$14 thousand
Optionable
Not Optionable
Beta
1.20
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:APRI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners